About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04090892

Effects of Soft Tissue Lengthening on Gait in Children With Spasticity

This research project is being conducted to investigate changes in secondary impairments, functional mobility skills, and gait variables in children with spasticity following selective percutaneous my...

Lead sponsor: University of Texas Southwestern Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Texas Southwestern Medical Center

Age

4 - 21 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Scheduled for an selective percutaneous myofascial lengthening procedure,
•Between the ages of 4.0 and 20.11 years old,
•Lower extremity spasticity,
•Able to ambulate 50 feet without a rest, with or without an assistive device, and with or without ankle foot orthoses (AFOs) and
•Able to follow one step directions.

Exclusion Criteria

•Botox injections into any lower extremity muscle within three months of the scheduled selective percutaneous myofascial lengthening procedure,
•Lower extremity orthopedic surgery within 6 months of the scheduled selective percutaneous myofascial lengthening procedure,
•Visual impairment that interferes with maintaining a straight path while ambulating,
•Uncontrolled seizure disorder
•A change in medication that affects spasticity or ability to follow one step directions within three months of the scheduled selective percutaneous myofascial lengthening procedure.

Related studies

Exoskeleton and Spinal Cord Stimulation for SCI

NCT03096197 · Spinal Cord Injury, Ambulation Difficulty, and more

Comparing Upper Limb Surgery and Botulinum Toxin for Spasticity: A Paired Design Study

NCT06733025 · Muscle Spasticity, Spinal Cord Injury, and more

SIRS-ESWT Trial: Shoulder Internal Rotator Spasticity Trial Treated With Extracorporeal Shock Wave Therapy Trial

NCT06674785 · Stroke, Muscle Spasticity

Upper-limb Active Function and Botulinum Toxin a

NCT03783572 · Stroke, Muscle Spasticity, and more

Active Not RecruitingPhase 2

Peripheral Modulation of Muscle Stiffness and Spasticity

NCT03306615 · Muscle Spasticity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 16, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment8

Start dateMay 2016

Last updatedSep 16, 2019

Condition

Muscle Spasticity

Locations shown

Children's Medical Center

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 16, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions